Cost-related non-adherence lowest among those with employer-sponsored plans.
The Canadian Institute of Actuaries suggests that the federal government fund public plans and assist private insurers i
More than 50 per cent of costs incurred by just five per cent of claimants.
Considered aesthetic medications, drugs for treating obesity are not covered by public healthcare systems.
Statistics Canada report examines medication use, out of pocket spending and non-adherence.
Biologic drugs, mental health and diabetes, all significant cost drivers, were each examined at a recent webinar.
Overprescribing costs $2 billion a year.